Foxo BioScience

Foxo BioScience is a company listed under the stock ticker FOXO (US).

View the org chart displaying its 8 main executives

Most searched biographies at Foxo BioScience

• Bret Barnes, Chairman of the Board
• Murdoc Khaleghi, Director
• Francis Colt deWolf, Director

Popular executive movements at Foxo BioScience

• Francis Colt deWolf has joined the company as Director  (posted on January 26 2024).
• Robby Potashnick, Chief Financial Officer, will leave the company on Sep. 13, 2023  (posted on August 25 2023).

Create your alert
to follow the executive moves at Foxo BioScience.

Foxo BioScience has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).
• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Foxo BioScience

• FOXO Technologies Inc. Class A Common Stock (FOXO) Press Releases | NasdaqBack ButtonSearch IconFilter Icon
• FOXO Technologies™ Collaborates with DataRobot to Pave the Way for AI-Driven Epigenetic Biomarker Research in Human Longevity
• FOXO Technologies™ Announces Second Quarter 2023 Financial Results
• Longevity Biotech Companies GERO and FOXO Technologies™ to Embark on Joint Initiative on Artificial Intelligence and Epigenetic Data to Discover Signatures of Human Health Trajectories
• FOXO Technologies Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis
• FOXO Technologies Announces Direct-to-Consumer Launch of Longevity Report Beta Product
• FOXO Technologies™ Announces First Quarter 2023 Financial Results
• FOXO Technologies™ Announces Full Year 2022 Financial Results and Recent Business Highlights
• FOXO Technologies Appoints Taylor Fay as Chief Operating Officer
• View more press releases Close

Social media about Foxo BioScience

• Foxo BioScience on Wikipedia, Google News & Yahoo Finance
• Foxo BioScience on LinkedIn, Twitter & YouTube

Contact by email its executives including Bret Barnes

Call Foxo BioScience at +1 877...

View the org chart

Register to receive your alert

Report an error